A citation-based method for searching scientific literature

Haleh Chehregosha, Mohammad E Khamseh, Mojtaba Malek, Farhad Hosseinpanah, Faramarz Ismail-Beigi. Diabetes Ther 2019
Times Cited: 30







List of co-cited articles
87 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
560
33

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
542
26


Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice.
Mary L Johnson, Thomas W Martens, Amy B Criego, Anders L Carlson, Gregg D Simonson, Richard M Bergenstal. Diabetes Technol Ther 2019
24
20

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
185
16


The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.
Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
133
13

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
129
13

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
120
13

Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.
Guillermo E Umpierrez, Boris P Kovatchev. Am J Med Sci 2018
26
15

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
131
13

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
13

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
97
13


Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.
Lorena Alarcon-Casas Wright, Irl B Hirsch. Diabetes Technol Ther 2017
70
13

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
99
13

Potential Clinical Error Arising From Use of HbA1c in Diabetes: Effects of the Glycation Gap.
Ananth U Nayak, Baldev M Singh, Simon J Dunmore. Endocr Rev 2019
16
18


Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
Tonya D Riddlesworth, Roy W Beck, Robin L Gal, Crystal G Connor, Richard M Bergenstal, Sooji Lee, Steven M Willi. Diabetes Technol Ther 2018
69
10


Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
208
10


Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
817
10

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
122
10

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
10



Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes.
J B Gillen, J P Little, Z Punthakee, M A Tarnopolsky, M C Riddell, M J Gibala. Diabetes Obes Metab 2012
123
6


Fear of hypoglycemia: Influence on glycemic variability and self-management behavior in young adults with type 1 diabetes.
Pamela Martyn-Nemeth, Laurie Quinn, Sue Penckofer, Chang Park, Vanessa Hofer, Larisa Burke. J Diabetes Complications 2017
41
6

Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial.
Matthew D Campbell, Mark Walker, Richard M Bracken, Daniel Turner, Emma J Stevenson, Javier T Gonzalez, James A Shaw, Daniel J West. BMJ Open Diabetes Res Care 2015
55
6


Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
John M Lachin, Saul Genuth, Patricia Cleary, Matthew D Davis, David M Nathan. N Engl J Med 2000
6

Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
271
6

Estimating measures of interaction on an additive scale for preventive exposures.
Mirjam J Knol, Tyler J VanderWeele, Rolf H H Groenwold, Olaf H Klungel, Maroeska M Rovers, Diederick E Grobbee. Eur J Epidemiol 2011
250
6

Calculating measures of biological interaction.
Tomas Andersson, Lars Alfredsson, Henrik K√§llberg, Slobodan Zdravkovic, Anders Ahlbom. Eur J Epidemiol 2005
780
6

Obesity and hypertension.
Shu-Zhong Jiang, Wen Lu, Xue-Feng Zong, Hong-Yun Ruan, Yi Liu. Exp Ther Med 2016
81
6

Comparison of Different Obesity Indices for Predicting Incident Hypertension.
Mohsen Janghorbani, Ashraf Aminorroaya, Masoud Amini. High Blood Press Cardiovasc Prev 2017
20
10

Diabetes and hypertension: the bad companions.
Ele Ferrannini, William C Cushman. Lancet 2012
265
6

Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses.
Alice Redfern, Sanne A E Peters, Rong Luo, Yu Cheng, Chenxiong Li, Jiawen Wang, Craig Anderson, Haijun Wang, Robyn Norton. Hypertens Res 2019
8
25

[2010 Chinese guidelines for the management of hypertension].
Li-Sheng Liu. Zhonghua Xin Xue Guan Bing Za Zhi 2011
427
6


Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults.
Shuqian Liu, James M Hempe, Robert J McCarter, Shengxu Li, Vivian A Fonseca. J Clin Endocrinol Metab 2015
31
6

Translating the A1C assay into estimated average glucose values.
David M Nathan, Judith Kuenen, Rikke Borg, Hui Zheng, David Schoenfeld, Robert J Heine. Diabetes Care 2008
871
6

The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial.
James M Hempe, Shuqian Liu, Leann Myers, Robert J McCarter, John B Buse, Vivian Fonseca. Diabetes Care 2015
80
6


Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.
Emma G Wilmot, Pratik Choudhary, Lalantha Leelarathna, Mike Baxter. Diabetes Obes Metab 2019
11
18

High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.
James M Hempe, Ricardo Gomez, Robert J McCarter, Stuart A Chalew. J Diabetes Complications 2002
160
6


Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
679
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.